摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methylsulfanyl-3,6-dihydro-2H-1,4-oxazine | 343307-36-8

中文名称
——
中文别名
——
英文名称
5-methylsulfanyl-3,6-dihydro-2H-1,4-oxazine
英文别名
5-(methylsulfanyl)-3,6-dihydro-2H-oxazine;5,6-dihydro-2H-1,4-oxazin-3-yl methyl sulphide;5-Methylthio-3,6-dihydro-2H-[1,4]oxazine
5-methylsulfanyl-3,6-dihydro-2H-1,4-oxazine化学式
CAS
343307-36-8
化学式
C5H9NOS
mdl
——
分子量
131.199
InChiKey
GXQPVPNALQNROT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    202.9±33.0 °C(Predicted)
  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    46.9
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    5-methylsulfanyl-3,6-dihydro-2H-1,4-oxazine 在 ammonium chloride 作用下, 以 乙醇 为溶剂, 以97.7%的产率得到3-iminomorpholin hydrochloride
    参考文献:
    名称:
    Process for preparing 6-alkylidene penem derivatives
    摘要:
    本发明提供了一种制备式I化合物的方法,该化合物对治疗细菌感染或疾病有用。
    公开号:
    US20040132708A1
  • 作为产物:
    描述:
    morpholine-3-thione碘甲烷二氯甲烷 为溶剂, 反应 15.0h, 以67.8%的产率得到5-methylsulfanyl-3,6-dihydro-2H-1,4-oxazine
    参考文献:
    名称:
    [EN] PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES
    [FR] PROCEDE DE PREPARATION DE DERIVES DE 6-ALKYLIDENE PENEM
    摘要:
    本发明提供了一种制备化合物的方法,该化合物符合式(I),对于治疗细菌感染或疾病非常有用。
    公开号:
    WO2003093277A1
点击查看最新优质反应信息

文献信息

  • Aryl-substituted heterocyclic enaminones
    申请人:Fischer Reiner
    公开号:US20060069253A1
    公开(公告)日:2006-03-30
    The invention relates to novel heterocyclic enaminones of the general formula (I) in which Ar, Z, K, X, y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 and V are as defined in the description, to their use as herbicides, acaricides and insecticides, and to processes for their preparation.
    该发明涉及一种新型杂环烯酮,其一般化学式为(I),其中Ar、Z、K、X、y1、Y2、Y3、Y4、Y5、Y6和V的定义如描述中所示,用作除草剂、杀螨剂和杀虫剂,并涉及其制备方法。
  • Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors
    申请人:Mansour Suhayl Tarek
    公开号:US20060276445A1
    公开(公告)日:2006-12-07
    This invention relates to certain bicyclic 6-alkylidene penems which act as a inhibitor of class-D enzymes. β-Lactamases hydrolyze β-lactam antibiotics, and as such serve as the primary cause of bacterial resistance. The compounds of the present invention when combined with β-lactam antibiotics will provide an effective treatment against life threatening bacterial infections. In accordance with the present invention there are provided compounds of general formula I or a pharmaceutically acceptable salt or in vivo hydrolyzable ester R 5 thereof: wherein: One of A and B denotes hydrogen and the other an optionally substituted fused bicyclic heteroaryl group; and X═O or S.
    这项发明涉及某些具有双环6-烷基亚烯基青霉素结构的化合物,其作为D类酶的抑制剂。β-内酰胺酶水解β-内酰胺类抗生素,因此是细菌耐药的主要原因。本发明的化合物与β-内酰胺类抗生素结合后,将提供一种有效的治疗方法,用于治疗威胁生命的细菌感染。根据本发明,提供了一般式I的化合物,或其药学上可接受的盐或体内可水解的酯R5:其中:A和B中的一个表示氢,另一个表示可选择取代的融合双环杂环芳基团;X=O或S。
  • [EN] BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS<br/>[FR] PENEMES 6-ALKYLIDENE BICYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE ss-LACTAMASES
    申请人:WYETH CORP
    公开号:WO2003093279A1
    公开(公告)日:2003-11-13
    The present invention provides a compound of Formula (I), pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof.
    本发明提供了一种化合物(I)的配方、药物组合物以及其用于治疗患有细菌感染或疾病的患者的用途。
  • Tetrahydropyranyl Benzamide Derivatives
    申请人:Eli Lilly and Company
    公开号:US20180194755A1
    公开(公告)日:2018-07-12
    The present invention provides compounds of the Formula below wherein R, R1-R3 are as described herein; methods of treating patients for diabetes using the compounds, and processes for preparing the compounds
    本发明提供了以下式中的化合物,其中R、R1-R3如本说明书所述;利用这些化合物治疗糖尿病患者的方法,以及制备这些化合物的过程。
  • 一种巴洛沙韦中间体的合成方法
    申请人:深圳市华先医药科技有限公司
    公开号:CN109516998B
    公开(公告)日:2021-06-25
    本发明公开了一种巴洛沙韦中间体的合成方法;属于有机化学合成领域。本发明方法以吡啶酮出发,经脱保护,缩合,手性还原得到巴洛沙韦的关键中间体。本发明的工艺路线简短,条件温和,不需要进行手性拆分即可获得较高的手性纯度,在易于产业化的同时,进一步降低巴洛沙韦的生产成本。
查看更多

同类化合物

乙基6H-1,2-恶嗪-3-羧酸酯 6-乙氧基-6H-1,2-恶嗪-3-甲醛 6-乙氧基-3-苯基-6H-1,2-恶嗪 5-甲氧基-3,6-二氢-2H-[1,4]恶嗪 5-乙氧基-3,6-二氢-2H-1,4-恶嗪 5,6-二氢-2H-1,4-恶嗪-3-胺 4H-1,4-恶嗪 3H-咪唑并[2,1-c][1,4]恶嗪 3-甲基-5-苯基-2H-1,4-恶嗪 3,5-二苯基-2H-1,4-恶嗪 3,5,5,6-四甲基-5,6-二氢-2H-1,4-恶嗪-2-酮 2H-[1,4]恶嗪并[3,4-b][1,3]恶嗪 2H-1,4-恶嗪 2H-1,4-噁嗪-2-酮,5,6-二氢-5-(1-甲基乙基)-3-苯基-,(S)- 2H-1,4-噁嗪-2-酮,3-(1,1-二甲基乙基)-5,6-二氢-5-苯基-,(R)- 2H-1,3-恶嗪 2H-1,2-恶嗪 2-(二甲基氨基)-4-苯基-4H-1,3-恶嗪-5-甲醛 (5S)-5,6-二氢-6,6-二甲基-5-苯基-2H-1,4-恶嗪-2-酮 6-amino-4-phenyl-4H-1,2-oxazine-3,5-dicarbonitrile (2S,5R)-2-hydroxy-5,6-dihydro-2-ethyl-3-methyl-5-phenyl-2H-1,4-oxazine (2S,5R)-2-hydroxy-5,6-dihydro-3-methyl-2,5-diphenyl-2H-1,4-oxazine (2S,5R,6R)-2-hydroxy-5,6-dihydro-2,3-diethyl-5-methyl-6-phenyl-2H-1,4-oxazine (2S,5R)-2-hydroxy-5,6-dihydro-2,3-diethyl-5-phenyl-2H-1,4-oxazine (2S,5S,6R)-2-hydroxy-5,6-dihydro-2,3,5-trimethyl-6-phenyl-2H-1,4-oxazine (2S,5S,6R)-2-hydroxy-5,6-dihydro-2,3-diethyl-5-methyl-6-phenyl-2H-1,4-oxazine (2S,5S,6R)-2-hydroxy-5,6-dihydro-3,5-dimethyl-6-phenyl-2-propyl-2H-1,4-oxazine (Z)-methyl-2-((R)-5-(2-(methylthio)ethyl)-3-oxomorpholin-2-ylidene)acetate (Z)-methyl-2-((R)-5-benzyl-3-oxomorpholin-2-ylidene)acetate (2R,5R,6S)-5,6-dihydro-3,6-diphenyl-2-hydroxy-5-methyl-1,4-oxazine (2S,5R,6R)-2-hydroxy-5,6-dihydro-2-ethyl-3,5-dimethyl-6-phenyl-2H-1,4-oxazine (2S,5S,6R)-2-hydroxy-5,6-dihydro-2-ethyl-3,5-dimethyl-6-phenyl-2H-1,4-oxazine 2-heptafluoropropyl-3-trifluoromethyl-5,6-dihydro-1,4-oxazin-2-ol (2S,5R,6R)-2-hydroxy-5,6-dihydro-3,5-dimethyl-2,6-diphenyl-2H-1,4-oxazine (2S,5S,6R)-2-hydroxy-5,6-dihydro-3,5-dimethyl-2,6-diphenyl-2H-1,4-oxazine 6H-1,2-Oxazine 4,4,6-Trimethyl-2-dimethylamino-4H-1,3-oxazine 3-(chloromethyl)-5,6-dihydro-5,5-dimethyl-1,4-oxazin-2-one 3-(acetoxymethyl)-5,6-dihydro-5,5-dimethyl-1,4-oxazin-2-one 6-Butyl-2,4-diphenyl-4H-[1,3]oxazine 2-methyl-2,4,6-triphenyl-2H-1,3-oxazine (S)-2,4,6-triphenyl-4H-1,3-oxazine 2-Isopropenyl-6-phenyl-6-piperidin-1-yl-6H-[1,3]oxazin-4-ol 5-methyl-6-perhydroxy-3-phenyl-6H-1,2-oxazine 5-methyl-3-phenyl-6-(prop-2-yn-1-oxy)-6H-1,2-oxazine 2,2,3,3,6,6-Hexafluoro-5-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-3,6-dihydro-2H-[1,4]oxazine 4,4-Dimethyl-2-phenyl-1,3-oxazine (R)-3-(but-3-enyl)-5-phenyl-5,6-dihydro-2H-1,4-oxazin-2-one Acetic acid 3,5-dimethyl-6-oxo-3,6-dihydro-2H-[1,4]oxazin-3-ylmethyl ester (2R,5R)-3-methyl-5-phenyl-2-(trifluoromethyl)-5,6-dihydro-2H-1,4-oxazin-2-ol